Enteral nutrition for maintaining remission in patients with quiescent Crohn’s disease: current status and future perspectives

International Journal of Colorectal Disease

Volumn 31, Issue 1, 2016, Pages 1-7

  Nakahigashi, Maki ^a,b   Yamamoto, Takayuki ^c   Sacco, Rodolfo ^d   Hanai, Hiroyuki ^e   Kobayashi, Fumio ^a  

^a AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SUZUKA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^c Yokkaichi Hazu Medical Centre   (Japan)

^d UNIVERSITY HOSPITAL OF PISA   (Italy)

^e Hamamatsu South Hospital   (Japan)

Author keywords

Crohn s disease; Elemental diet; Enteral nutrition; Maintenance therapy; Remission

Indexed keywords

INFLIXIMAB; MESALAZINE;

CALORIC INTAKE; CROHN DISEASE; DIET; ENTERIC FEEDING; HUMAN; MAINTENANCE THERAPY; MUCOSA INFLAMMATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMISSION; REVIEW; STEROID THERAPY; INFLAMMATION; INTESTINE MUCOSA; PATHOLOGY; TREATMENT OUTCOME; TRENDS;

CROHN DISEASE; ENTERAL NUTRITION; HUMANS; INFLAMMATION; INTESTINAL MUCOSA; REMISSION INDUCTION; TREATMENT OUTCOME;

EID: 84953348511     PISSN: 01791958     EISSN: 14321262     Source Type: Journal    
DOI: 10.1007/s00384-015-2348-x     Document Type: Review

References (23)

1. O’Sullivan M, O’Morain C (2006) Nutrition in inflammatory bowel disease. Best Pract Res Clin Gastroenterol 20:561–573
2. Razack R, Seidner DL (2007) Nutrition in inflammatory bowel disease. Curr Opin Gastroenterol 23:400–405
3. Mekhjian HS, Switz DM, Melnyk CS, Rankin GB, Brooks RK (1979) Clinical features and natural history of Crohn’s disease. Gastroenterology 77:898–906
4. Hodges P, Gee M, Grace M, Sherbaniuk RW, Wensel RH, Thomson AB (1984) Protein-energy intake and malnutrition in Crohn’s disease. J Am Diet Assoc 84:1460–1464
5. Yamamoto T, Nakahigashi M, Saniabadi AR (2009) Review article: diet and inflammatory bowel disease—epidemiology and treatment. Aliment Pharmacol Ther 30:99–112
6. Zachos M, Tondeur M, Griffiths AM (2007) Enteral nutritional therapy for induction of remission in Crohn’s disease. Cochrane Database Syst Rev 1, CD000542
7. Dziechciarz P, Horvath A, Shamir R, Szajewska H (2007) Meta-analysis: enteral nutrition in active Crohn’s disease in children. Aliment Pharmacol Ther 26:795–806
8. Lochs H, Dejong C, Hammarqvist F, Hebuterne X, Leon-Sanz M, Schütz T, van Gemert W, van Gossum A, Valentini L, DGEM (German Society for Nutritional Medicine), Lübke H, Bischoff S, Engelmann N, Thul P, ESPEN (European Society for Parenteral and Enteral Nutrition) (2006) ESPEN guidelines on enteral nutrition: gastroenterology. Clin Nutr 25:260–274
9. Verma S, Kirkwood B, Brown S, Giaffer MH (2000) Oral nutritional supplementation is effective in the maintenance of remission in Crohn’s disease. Dig Liver Dis 32:769–774
10. Verma S, Holdsworth CD, Giaffer MH (2001) Does adjuvant nutritional support diminish steroid dependency in Crohn disease? Scand J Gastroenterol 36:383–388
11. Takagi S, Utsunomiya K, Kuriyama S, Yokoyama H, Takahashi S, Iwabuchi M, Takahashi H, Takahashi S, Kinouchi Y, Hiwatashi N, Funayama Y, Sasaki I, Tsuji I, Shimosegawa T (2006) Effectiveness of an ‘half elemental diet’ as maintenance therapy for Crohn’s disease: a randomized-controlled trial. Aliment Pharmacol Ther 24:1333–1340
12. Yamamoto T, Nakahigashi M, Saniabadi AR, Iwata T, Maruyama Y, Umegae S, Matsumoto K (2007) Impacts of long-term enteral nutrition on clinical and endoscopic disease activities and mucosal cytokines during remission in patients with Crohn’s disease: a prospective study. Inflamm Bowel Dis 13:1493–1501
13. Yamamoto T, Nakahigashi M, Umegae S, Kitagawa T, Matsumoto K (2007) Impact of long-term enteral nutrition on clinical and endoscopic recurrence after resection for Crohn’s disease: a prospective, non-randomized, parallel, controlled study. Aliment Pharmacol Ther 25:67–72
14. Yamamoto T, Nakahigashi M, Umegae S, Matsumoto K (2010) Prospective clinical trial: enteral nutrition during maintenance infliximab in Crohn’s disease. J Gastroenterol 45:24–29
15. Hanai H, Iida T, Takeuchi K, Arai H, Arai O, Abe J, Tanaka T, Maruyama Y, Ikeya K, Sugimoto K, Nakamura T, Nakamura K, Watanabe F (2012) Nutritional therapy versus 6-mercaptopurine as maintenance therapy in patients with Crohn’s disease. Dig Liver Dis 44:649–654
16. Best WR, Becktel JM, Singleton JW, Kern F Jr (1976) Development of a Crohn’s disease activity index. National Cooperative Crohn’s Dis Study Gastroenterol 70:439–444
17. Wardle TD, Hall L, Turnberg LA (1992) Use of coculture of colonic mucosal biopsies to investigate the release of eicosanoids by inflamed and uninflamed mucosa from patients with inflammatory bowel disease. Gut 33:1644–1651
18. Rutgeerts P, Geboes K, Vantrappen G, Beyls J, Kerremans R, Hiele M (1990) Predictability of the postoperative course of Crohn’s disease. Gastroenterology 99:956–963
19. Yamamoto T, Shiraki M, Nakahigashi M, Umegae S, Matsumoto K (2013) Enteral nutrition to suppress postoperative Crohn’s disease recurrence: a five-year prospective cohort study. Int J Color Dis 28:335–340
20. Hirakawa H, Fukuda Y, Tanida N, Hosomi M, Shimoyama T (1993) Home elemental enteral hyperalimentation (HEEH) for the maintenance of remission in patients with Crohn’s disease. Gastroenterol Jpn 28:379–384
21. Esaki M, Matsumoto T, Nakamura S, Yada S, Fujisawa K, Jo Y, Iida M (2006) Factors affecting recurrence in patients with Crohn’s disease under nutritional therapy. Dis Colon Rectum 49(10 Suppl):S68–S74
22. Sanderson IR, Boulton P, Menzies I, Walker-Smith JA (1987) Improvement of abnormal lactulose/rhamnose permeability in active Crohn’s disease of the small bowel by an elemental diet. Gut 28:1073–1076
23. Fell JM, Paintin M, Arnaud-Battandier F, Beattie RM, Hollis A, Kitching P, Donnet-Hughes A, MacDonald TT, Walker-Smith JA (2000) Mucosal healing and a fall in mucosal pro-inflammatory cytokine mRNA induced by a specific oral polymeric diet in paediatric Crohn’s disease. Aliment Pharmacol Ther 14:281–289